Shares of Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) rose 6% during trading on Thursday . The stock traded as high as $56.44 and last traded at $56.40. Approximately 11,574,458 shares were traded during trading, an increase of 75% from the average daily volume of 6,620,278 shares. The stock had previously closed at $53.20.
Analyst Ratings Changes
A number of brokerages have recently weighed in on TEM. William Blair restated a "market perform" rating on shares of Tempus AI in a report on Tuesday, February 25th. Piper Sandler boosted their price target on shares of Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a research note on Thursday, May 15th. Morgan Stanley upped their price target on shares of Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. JPMorgan Chase & Co. downgraded Tempus AI from an "overweight" rating to a "neutral" rating and lifted their price objective for the stock from $50.00 to $55.00 in a report on Tuesday, February 25th. Finally, Guggenheim restated a "buy" rating on shares of Tempus AI in a report on Tuesday, February 25th. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, Tempus AI has an average rating of "Moderate Buy" and an average target price of $63.42.
Get Our Latest Stock Report on TEM
Tempus AI Price Performance
The stock has a market cap of $9.45 billion and a P/E ratio of -7.00. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The firm has a 50-day moving average price of $52.07 and a 200-day moving average price of $51.79.
Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. The business had revenue of $255.74 million for the quarter, compared to analysts' expectations of $248.13 million. Tempus AI's quarterly revenue was up 75.4% on a year-over-year basis. On average, analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.
Insider Transactions at Tempus AI
In other Tempus AI news, CAO Ryan M. Bartolucci sold 6,073 shares of the business's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $63.23, for a total value of $383,995.79. Following the completion of the transaction, the chief accounting officer now owns 47,799 shares of the company's stock, valued at approximately $3,022,330.77. The trade was a 11.27% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Andrew Polovin sold 13,135 shares of the company's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $45.98, for a total transaction of $603,947.30. Following the transaction, the executive vice president now owns 154,171 shares in the company, valued at $7,088,782.58. This represents a 7.85% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 723,042 shares of company stock valued at $37,642,690 in the last ninety days. 27.60% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in TEM. First Horizon Advisors Inc. raised its stake in Tempus AI by 12.7% during the 1st quarter. First Horizon Advisors Inc. now owns 1,849 shares of the company's stock valued at $89,000 after buying an additional 208 shares during the last quarter. Wells Fargo & Company MN increased its position in Tempus AI by 13.2% during the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock valued at $80,000 after acquiring an additional 278 shares during the last quarter. Bartlett & CO. Wealth Management LLC lifted its holdings in Tempus AI by 100.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock valued at $39,000 after acquiring an additional 400 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its position in Tempus AI by 10.1% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,594 shares of the company's stock worth $268,000 after purchasing an additional 515 shares during the last quarter. Finally, Cherry Tree Wealth Management LLC purchased a new position in Tempus AI in the first quarter worth about $31,000. Institutional investors own 24.22% of the company's stock.
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Read More
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
